Exhibit

We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of Bausch Health Companies Inc. (formerly known as Valeant Pharmaceuticals International, Inc.) of our report dated February 28, 2018, except with respect to our opinion on the consolidated financial statements insofar as it relates to the change in composition of reportable segments discussed in Note 23, as to which the date is August 10, 2018, relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in Bausch Health Companies Inc.’s Current Report on Form 8-K dated August 10, 2018.